CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The OFB-SCI project aims to enhance cancer immunotherapy by developing advanced polymeric substrates that promote the proliferation of T cells. This technology seeks to improve the efficiency of T cell production for cancer treatment.
Harnessing the power of the immune system to fight malignancies remains a challenging goal although important progress has recently been achieved.
For example, cancer remission of terminal leukemia patients was accomplished with genetically modified autologous T cells (Dr.
June, University of Pennsylvania, 2011).
However, these adoptive T cell therapies are limited by the availability of target specific T cells that are extracted from each patient, expanded ex vivo, and transferred back to the p…
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
